PubMed:9499378
Annnotations
GlyCosmos6-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 95-99 | Body_part | denotes | cell | http://purl.obolibrary.org/obo/CL_0000000 |
T2 | 301-305 | Body_part | denotes | cell | http://purl.obolibrary.org/obo/CL_0000000 |
T3 | 718-722 | Body_part | denotes | cell | http://purl.obolibrary.org/obo/CL_0000000 |
T4 | 1094-1098 | Body_part | denotes | cell | http://purl.obolibrary.org/obo/CL_0000000 |
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-26 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sialyl Lewis x |
T2 | 195-199 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T3 | 227-231 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T4 | 573-577 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T5 | 649-653 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T6 | 670-674 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T7 | 768-772 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T8 | 898-902 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T9 | 928-932 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T10 | 974-978 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T11 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T12 | 1226-1230 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T13 | 1263-1267 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T14 | 1321-1325 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 12-26 | Glycan_Motif | denotes | sialyl Lewis x | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T2 | 19-26 | Glycan_Motif | denotes | Lewis x | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00051MO |
T4 | 195-199 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T5 | 227-231 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T6 | 573-577 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T7 | 649-653 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T8 | 670-674 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T9 | 768-772 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T10 | 898-902 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T11 | 928-932 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T12 | 974-978 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T13 | 1199-1203 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T14 | 1226-1230 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T15 | 1263-1267 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
T16 | 1321-1325 | Glycan_Motif | denotes | sLex | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-26 | http://www.glycoepitope.jp/epitopes/EP0012 | denotes | sialyl Lewis x |
T2 | 19-26 | http://www.glycoepitope.jp/epitopes/EP0011 | denotes | Lewis x |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-109 | Sentence | denotes | Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion. |
TextSentencer_T2 | 110-314 | Sentence | denotes | We report on the efficiencies of structurally different but well defined multivalent sLex-ligands (di- and trivalent sLex-peptides and sLexbearing liposomes) to block receptor mediated HepG2-cell binding. |
TextSentencer_T3 | 315-586 | Sentence | denotes | Using three types of binding assays with distinct receptor accommodations (soluble anti-sLexmonoclonal antibody CSLEX1, immobilized E-selectin, activated HUVECs), we quantified considerable differences of the inhibition efficiencies for the same multivalent sLex-ligands. |
TextSentencer_T4 | 587-808 | Sentence | denotes | Compared to the monovalent sLexthe inhibition powers of both (sLex)2-peptides and (sLex)3-peptides were enhanced up to 50-fold for cell binding to the soluble antibody, and that of sLex-liposomes by 7 orders of magnitude. |
TextSentencer_T5 | 809-1003 | Sentence | denotes | Directed to immobilized E-selectin the inhibition activity was enhanced only 3-fold for (sLex)2-peptides, 10-fold for (sLex)3-peptides but 5 orders of magnitude for sLex-liposomes, respectively. |
TextSentencer_T6 | 1004-1127 | Sentence | denotes | Further decrease of the inhibition efficiencies of glycoligands prepared was observed for cell binding to activated HUVECs. |
TextSentencer_T7 | 1128-1278 | Sentence | denotes | Compared to monovalent sLexwe measured relative efficiencies of 1 for (sLex)2-peptides, of 2 for (sLex)3-peptides but about 20,000 for sLex-liposomes. |
TextSentencer_T8 | 1279-1421 | Sentence | denotes | We concluded that the multivalency of the sLex-ligands prepared is an essential but not sufficient precondition for a high inhibition potency. |
TextSentencer_T9 | 1422-1582 | Sentence | denotes | Additionally, structural properties of the inhibitors determine their binding behavior, which must be considered for the design of potential therapeutic probes. |
T1 | 0-109 | Sentence | denotes | Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion. |
T2 | 110-314 | Sentence | denotes | We report on the efficiencies of structurally different but well defined multivalent sLex-ligands (di- and trivalent sLex-peptides and sLexbearing liposomes) to block receptor mediated HepG2-cell binding. |
T3 | 315-586 | Sentence | denotes | Using three types of binding assays with distinct receptor accommodations (soluble anti-sLexmonoclonal antibody CSLEX1, immobilized E-selectin, activated HUVECs), we quantified considerable differences of the inhibition efficiencies for the same multivalent sLex-ligands. |
T4 | 587-808 | Sentence | denotes | Compared to the monovalent sLexthe inhibition powers of both (sLex)2-peptides and (sLex)3-peptides were enhanced up to 50-fold for cell binding to the soluble antibody, and that of sLex-liposomes by 7 orders of magnitude. |
T5 | 809-1003 | Sentence | denotes | Directed to immobilized E-selectin the inhibition activity was enhanced only 3-fold for (sLex)2-peptides, 10-fold for (sLex)3-peptides but 5 orders of magnitude for sLex-liposomes, respectively. |
T6 | 1004-1127 | Sentence | denotes | Further decrease of the inhibition efficiencies of glycoligands prepared was observed for cell binding to activated HUVECs. |
T7 | 1128-1278 | Sentence | denotes | Compared to monovalent sLexwe measured relative efficiencies of 1 for (sLex)2-peptides, of 2 for (sLex)3-peptides but about 20,000 for sLex-liposomes. |
T8 | 1279-1421 | Sentence | denotes | We concluded that the multivalency of the sLex-ligands prepared is an essential but not sufficient precondition for a high inhibition potency. |
T9 | 1422-1582 | Sentence | denotes | Additionally, structural properties of the inhibitors determine their binding behavior, which must be considered for the design of potential therapeutic probes. |
T1 | 0-109 | Sentence | denotes | Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion. |
T2 | 110-314 | Sentence | denotes | We report on the efficiencies of structurally different but well defined multivalent sLex-ligands (di- and trivalent sLex-peptides and sLexbearing liposomes) to block receptor mediated HepG2-cell binding. |
T3 | 315-586 | Sentence | denotes | Using three types of binding assays with distinct receptor accommodations (soluble anti-sLexmonoclonal antibody CSLEX1, immobilized E-selectin, activated HUVECs), we quantified considerable differences of the inhibition efficiencies for the same multivalent sLex-ligands. |
T4 | 587-808 | Sentence | denotes | Compared to the monovalent sLexthe inhibition powers of both (sLex)2-peptides and (sLex)3-peptides were enhanced up to 50-fold for cell binding to the soluble antibody, and that of sLex-liposomes by 7 orders of magnitude. |
T5 | 809-1003 | Sentence | denotes | Directed to immobilized E-selectin the inhibition activity was enhanced only 3-fold for (sLex)2-peptides, 10-fold for (sLex)3-peptides but 5 orders of magnitude for sLex-liposomes, respectively. |
T6 | 1004-1127 | Sentence | denotes | Further decrease of the inhibition efficiencies of glycoligands prepared was observed for cell binding to activated HUVECs. |
T7 | 1128-1278 | Sentence | denotes | Compared to monovalent sLexwe measured relative efficiencies of 1 for (sLex)2-peptides, of 2 for (sLex)3-peptides but about 20,000 for sLex-liposomes. |
T8 | 1279-1421 | Sentence | denotes | We concluded that the multivalency of the sLex-ligands prepared is an essential but not sufficient precondition for a high inhibition potency. |
T9 | 1422-1582 | Sentence | denotes | Additionally, structural properties of the inhibitors determine their binding behavior, which must be considered for the design of potential therapeutic probes. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-26 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sialyl Lewis x |
T2 | 19-26 | https://glytoucan.org/Structures/Glycans/G00051MO | denotes | Lewis x |
T3 | 19-26 | https://glytoucan.org/Structures/Glycans/G01187XC | denotes | Lewis x |
T4 | 195-199 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T5 | 227-231 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T6 | 573-577 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T7 | 649-653 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T8 | 670-674 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T9 | 768-772 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T10 | 898-902 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T11 | 928-932 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T12 | 974-978 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T13 | 1199-1203 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T14 | 1226-1230 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T15 | 1263-1267 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
T16 | 1321-1325 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | sLex |
GlyCosmos6-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 95-99 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T2 | 295-305 | http://purl.obolibrary.org/obo/CLO_0051862 | denotes | HepG2-cell |
T3 | 301-305 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T4 | 459-468 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T5 | 469-475 | http://purl.obolibrary.org/obo/CLO_0004307 | denotes | HUVECs |
T6 | 718-722 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T7 | 859-867 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T8 | 1094-1098 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T9 | 1110-1119 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T10 | 1120-1126 | http://purl.obolibrary.org/obo/CLO_0004307 | denotes | HUVECs |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 75-85 | FMAID:62933 | denotes | E-selectin |
_T2 | 75-85 | FMAID:167265 | denotes | E-selectin |
_T3 | 75-85 | FMAID:167267 | denotes | E-selectin |
_T4 | 75-85 | FMAID:62932 | denotes | E-selectin |
_T5 | 75-85 | FMAID:62931 | denotes | E-selectin |
_T6 | 75-85 | FMAID:167268 | denotes | E-selectin |
_T7 | 77-85 | FMAID:165243 | denotes | selectin |
_T8 | 77-85 | FMAID:61795 | denotes | selectin |
_T9 | 418-426 | FMAID:167180 | denotes | antibody |
_T10 | 447-457 | FMAID:62932 | denotes | E-selectin |
_T11 | 447-457 | FMAID:62931 | denotes | E-selectin |
_T12 | 447-457 | FMAID:167267 | denotes | E-selectin |
_T13 | 447-457 | FMAID:167268 | denotes | E-selectin |
_T14 | 447-457 | FMAID:62933 | denotes | E-selectin |
_T15 | 447-457 | FMAID:167265 | denotes | E-selectin |
_T16 | 449-457 | FMAID:61795 | denotes | selectin |
_T17 | 449-457 | FMAID:165243 | denotes | selectin |
_T18 | 746-754 | FMAID:167180 | denotes | antibody |
_T19 | 833-843 | FMAID:62932 | denotes | E-selectin |
_T20 | 833-843 | FMAID:167265 | denotes | E-selectin |
_T21 | 833-843 | FMAID:167268 | denotes | E-selectin |
_T22 | 833-843 | FMAID:167267 | denotes | E-selectin |
_T23 | 833-843 | FMAID:62933 | denotes | E-selectin |
_T24 | 833-843 | FMAID:62931 | denotes | E-selectin |
_T25 | 835-843 | FMAID:61795 | denotes | selectin |
_T26 | 835-843 | FMAID:165243 | denotes | selectin |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 75-85 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
T2 | 447-457 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
T3 | 833-843 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 75-85 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
T2 | 447-457 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
T3 | 833-843 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1500-1508 | http://purl.bioontology.org/ontology/STY/T053 | denotes | behavior |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-18 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialyl |
T2 | 86-108 | http://purl.obolibrary.org/obo/GO_0033627 | denotes | mediated cell adhesion |
T3 | 95-108 | http://purl.obolibrary.org/obo/GO_0007155 | denotes | cell adhesion |
T4 | 1099-1119 | http://purl.obolibrary.org/obo/GO_0051099 | denotes | binding to activated |
T5 | 1500-1508 | http://purl.obolibrary.org/obo/GO_0007610 | denotes | behavior |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 27-34 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | ligands |
T2 | 200-207 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | ligands |
T3 | 578-585 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | ligands |
T4 | 1326-1333 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | ligands |
T5 | 77-85 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
T6 | 449-457 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
T7 | 835-843 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
T8 | 306-313 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T9 | 336-343 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T10 | 723-730 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T11 | 1099-1106 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T12 | 1492-1499 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
T13 | 306-313 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T14 | 336-343 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T15 | 723-730 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T16 | 1099-1106 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T17 | 1492-1499 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
T18 | 306-313 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T19 | 336-343 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T20 | 723-730 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T21 | 1099-1106 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T22 | 1492-1499 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
T23 | 306-313 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T24 | 336-343 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T25 | 723-730 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T26 | 1099-1106 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T27 | 1492-1499 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
T28 | 418-426 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
T29 | 746-754 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 95-99 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T2 | 301-305 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T3 | 718-722 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T4 | 1094-1098 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
GlycoBiology-Motifs
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 12-24 | http://rdf.glycoinfo.org/glycan/G00053MO | denotes | sialyl Lewis |
T2 | 12-26 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sialyl Lewis x |
T3 | 19-24 | http://rdf.glycoinfo.org/glycan/G00047MO | denotes | Lewis |
T4 | 19-26 | http://rdf.glycoinfo.org/glycan/G00051MO | denotes | Lewis x |
T5 | 195-199 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T6 | 227-231 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T7 | 573-577 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T8 | 649-653 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T9 | 670-674 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T10 | 768-772 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T11 | 898-902 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T12 | 928-932 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T13 | 974-978 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T14 | 1199-1203 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T15 | 1226-1230 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T16 | 1263-1267 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
T17 | 1321-1325 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | sLex |
Lectin
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
Lectin_T1 | 75-85 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
Lectin_T2 | 447-457 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
Lectin_T3 | 833-843 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
Lectin_T4 | 77-85 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
Lectin_T5 | 449-457 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
Lectin_T6 | 835-843 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
Lectin_T7 | 77-85 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
Lectin_T8 | 449-457 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
Lectin_T9 | 835-843 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 19-26 | http://www.glycoepitope.jp/epitopes/EP0011 | denotes | Lewis x |
PD-GlycoEpitope-B_T2 | 12-24 | http://www.glycoepitope.jp/epitopes/EP0008 | denotes | sialyl Lewis |
PD-GlycoEpitope-B_T3 | 12-26 | http://www.glycoepitope.jp/epitopes/EP0012 | denotes | sialyl Lewis x |